Dynamic mutations as digital genetic modulators of brain development, function and dysfunction

BioEssays

Volumn 29, Issue 6, 2007, Pages 525-535

  Nithianantharajah, Jess ^a   Hannan, Anthony J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; MICROSATELLITE DNA;

ATAXIA; BRAIN DEVELOPMENT; BRAIN DYSFUNCTION; BRAIN FUNCTION; FRAGILE X SYNDROME; FRIEDREICH ATAXIA; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN GENETICS; HUNTINGTON CHOREA; NONHUMAN; NUCLEOTIDE SEQUENCE; REVIEW; SPINOCEREBELLAR DEGENERATION; TANDEM REPEAT; TREMOR; TRINUCLEOTIDE REPEAT;

BRAIN; EVOLUTION; HUMANS; MUTATION; NERVOUS SYSTEM DISEASES; PEPTIDES; RNA; TANDEM REPEAT SEQUENCES;

EID: 34250208181     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20589     Document Type: Review

References (115)

1. Hamada H, Seidman M, Howard BH, Gorman CM. 1984. Enhanced gene expression by the poly(dT-dG).poly(dC-dA) sequence. Mol Cell Biol 4:2622-2630.
2. Gerber HP, Seipel K, Georgiev O, Hofferer M, Hug M, et al. 1994 Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263:808-811.
3. King DG. 1994. Triple repeat DNA as a highly mutable regulatory mechanism. Science 263:595-596.
4. Kashi Y, King D, Soller M. 1997, Simple sequence repeats as a source of quantitative genetic variation. Trends Genet 13:74-78.
5. Sawyer LA, Hennessy JM, Peixoto AA, Rosato E, Parkinson H, et al. 1997. Natural variation in a Drosophila clock gene and temperature compensation. Science 278:2117-2120.
6. Nakamura Y, Koyama K, Matsushima M. 1998. VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. J Hum Genet 43:149-152.
7. Wren JD. Forgacs E, Fondon JW, 3rd. Pertsemlidis A, Cheng SY, et al. 2000. Repeat polymorphisms within gene regions: phenotypic and evolutionary implications. Am J Hum Genet 67:345-356.
8. Young ET, Sloan JS, Van Riper K. 2000. Trinucleotide repeats are clustered in regulatory genes in Saccharomyces cerevisiae. Genetics 154:1053-1068.
9. Karlin S, Brocchieri L, Bergman A, Mrazek J, Gentles AJ. 2002. Amino acid runs in eukaryotic proteomes and disease associations. Proc Natl Acad Sci USA 99:333-338.
10. Rockman MV, Wray GA. 2002. Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 19:1991-2004.
11. Fondon JW, 3rd, Garner HR. 2004. Molecular origins of rapid and continuous morphological evolution. Proc Natl Acad Sci USA 101:18058-18063.
12. Li YC, Korol AB, Fahima T, Nevo E. 2004. Microsatellites within genes: structure, function, and evolution. Mol Biol Evol 21:991-1007.
13. Hammock EA, Young LJ. 2005. Microsatellite instability generates diversity in brain and sociobehavioral traits. Science 308:1630-1634.
14. Thomas EE. 2005. Short, local duplications in eukaryotic genomes. Curr Opin Genet Dev 15:640-644.
15. Kashi Y, King DG. 2006. Simple sequence repeats as advantageous mutators in evolution. Trends Genet 22:253-259.
16. Rubinsztein DC, Leggo J, Amos W, Barton DE, Ferguson-Smith MA. 1994. Myotonic dystrophy CTG repeats and the associated insertion/deletion polymorphism in human and primate populations. Hum Mol Genet 3:2031-2035.
17. Rubinsztein DC, Amos W, Leggo J, Goodburn S, Jain S, et al. 1995. Microsatellite evolution-evidence for directionality and variation in rate between species. Nat Genet 10:337-343.
18. Rubinsztein DC, Leggo J, Amos W. 1995. Microsatellites evolve more rapidly in humans than in chimpanzees. Genomics 30:610-612.
19. Amos W, Sawcer SJ, Feakes RW, Rubinsztein DC. 1996. Microsatellites show mutational bias and heterozygote instability. Nat Genet 13:390-391.
20. Primmer CR, Saino N, Moller AP, Ellegren H. 1996. Directional evolution in germline microsatellite mutations. Nat Genet 13:391-393.
21. Cooper G, Rubinsztein DC, Amos W. 1998. Ascertainment bias cannot entirely account for human microsatellites being longer than their chimpanzee homologues. Hum Mol Genet 7:1425-1429.
22. Cooper G, Burroughs NJ, Rand DA, Rubinsztein DC, Amos W. 1999. Markov chain Monte Carlo analysis of human Y-chromosome microsatellites provides evidence of biased mutation. Proc Natl Acad Sci USA 96:11916-11921.
23. Tompa P. 2003. Intrinsically unstructured proteins evolve by repeat expansion. Bioessays 25:847-855.
24. Ellegren H. 2004. Microsatellites: simple sequences with complex evolution. Nat Rev Genet 5:435-445.
25. Pearson CE, Nichol Edamura K, Cleary JD. 2005. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 6:729-742.
26. Buschiazzo E, Gemmell NJ. 2006. The rise, fall and renaissance of microsatellites in eukaryotic genomes. Bioessays 28:1040-1050.
27. Richards RI, Sutherland GR. 1992. Dynamic mutations: a new class of mutations causing human disease. Cell 70:709-712.
28. van Dellen A, Grote HE, Hannan AJ. 2005. Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease. Clin Exp Pharmacol Physiol 32:1007-1019.
29. Verstrepen KJ, Jansen A, Lewitter F, Fink GR. 2005. Intragenic tandem repeats generate functional variability. Nat Genet 37:986-990.
30. Bond J, Roberts E, Mochida GH, Hampshire DJ, Scott S, et al. 2002. ASPM is a major determinant of cerebral cortical size. Nat Genet 32:316-320.
31. Pollard KS, Salama SR, Lambert N, Lambot MA, Coppens S, et al. 2006. An RNA gene expressed during cortical development evolved rapidly in humans. Nature 443:167-172.
32. Caburet S, Cocquet J, Vaiman D, Veitia RA. 2005. Coding repeats and evolutionary "agility". Bioessays 27:581-587.
33. Kijas JM, Moller M, Plastow G, Andersson L. 2001. A frameshift mutation in MC1R and a high frequency of somatic reversions cause black spotting in pigs. Genetics 158:779-785.
34. Kennedy L, Shelbourne PF. 2000. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease? Hum Mol Genet 9:2539-2544.
35. Farrell BT, Lahue RS. 2006. CAG*CTG repeat instability in cultured human astrocytes. Nucleic Acids Res 34:4495-4505.
36. Loesch DZ, Huggins RM, Hagerman RJ. 2004. Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev 10:31-41.
37. Faux NG, Bottomley SP, Lesk AM, Irving JA, Morrison JR, et al. 2005. Functional insights from the distribution and role of homopeptide repeat-containing proteins. Genome Res 15:537-551
38. Cattaneo E, Zuccato C, Tartari M. 2005. Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci 6:919-930.
39. Fink S, Excoffier L, Heckel G. 2006. Mammalian monogamy is not controlled by a single gene. Proc Natl Acad Sci USA 103:10956-10960.
40. Rubinsztein DC, Amos B, Cooper G. 1999. Microsatellite and trinucleotide-repeat evolution: evidence for mutational bias and different rates of evolution in different lineages. Philos Trans R Soc Lond B Biol Sci 354: 1095-1099.
41. Sainudiin R, Durrett RT, Aquadro CF, Nielsen R. 2004. Microsatellite mutation models: insights from a comparison of humans and chimpanzees. Genetics 168:383-395.
42. Vowles EJ, Amos W. 2004. Evidence for widespread convergent evolution around human microsatellites. PLoS Biol 2:E199.
43. Gatchel JR, Zoghbi HY. 2005. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet 6:743-755.
44. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. 1991. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79.
45. Koide R, Ikeuchi T, Onodera O, Tanaka H, Igarashi S, et al. 1994. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 6:9-13.
46. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, et al. 1994. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 8:221-228.
47. Imbert G, Saudou F, Yvert G, Devys D, Trottier Y, et al. 1996. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 14:285-291.
48. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, et al. 1997. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 15:62-69.
49. Huntington's Disease Collaborative Research Group. 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
50. van Dellen A, Blakemore C, Deacon R, York D, Hannan AJ. 2000. Delaying the onset of Huntington's in mice. Nature 404:721-722.
51. Hockly E, Cordery PM, Woodman B, Mahal A, van Dellen A, et al. 2002. Environmental enrichment slows disease progression in R6/2 Huntington's disease mice. Ann Neurol 51:235-242.
52. Spires TL, Grote HE, Varshney NK, Cordery PM, van Dellen A, et al. 2004. Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. J Neurosci 24:2270-2276
53. Nithianantharajah J, Hannan AJ. 2006. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat Rev Neurosci 7:697-709.
54. Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, et al. 2004. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci USA 101:3498-3503.
55. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, et al. 1996. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506.
56. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, et al. 1997. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537-548.
57. Cha JH, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, et al. 1998 Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci USA 95:6480-6485.
58. Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, et al. 2000. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet 9:1259-1271.
59. Usdin MT, Shelbourne PF, Myers RM, Madison DV. 1999. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum Mol Genet 8:839-846.
60. Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, et al. 1999. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181-192.
61. Murphy KP, Carter RJ, Lione LA, Mangiarini L, Mahal A, et al. 2000 Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J Neurosci 20:5115-5123.
62. Lazic SE, Grote H, Armstrong RJ, Blakemore C, Hannan AJ, et al. 2004. Decreased hippocampal cell proliferation in R6/1 Huntington's mice. Neuroreport 15:811-813.
63. Grote HE, Bull ND, Howard ML, van Dellen A, Blakemore C, et al. 2005. Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur J Neurosci 22:2081-2088.
64. Gil JM, Mohapel P, Araujo IM, Popovic N, Li JY, et al. 2005. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice. Neurobiol Dis 20:744-751.
65. Mazarakis NK, Cybulska-Klosowicz A, Grote H, Pang T, Van Dellen A, et al. 2005. Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice. J Neurosci 25:3059-3066.
66. Gusella JF, Macdonald ME. 2006. Huntington's disease: seeing the pathogenic process through a genetic lens. Trends Biochem Sci 31:533-540.
67. Spires TL, Hannan AJ. 2007. Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease. J Neurochem 100:874-882.
68. Igarashi S, Tanno Y, Onodera O, Yamazaki M, Sato S, et al. 1992. Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology 42:2300-2302.
69. Ross CA. 1997. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19:1147-1150.
70. Cummings CJ, Reinstein E, Sun Y, Antalffy B, Jiang Y, et al. 1999. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 24:879-892.
71. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, et al. 1998. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95:41-53.
72. Saudou F, Finkbeiner S, Devys D, Greenberg ME. 1998 Huntingtin acts in the nucleus to induce apoptosls but death does not correlate with the formation of intranuclear inclusions. Cell 95:55-66.
73. Nguyen HP, Kobbe P, Rahne H, Worpel T, Jager B, et al. 2006. Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease. Hum Mol Genet 15:3177-3194.
74. Slow EJ, Graham RK, Osmand AP, Devon RS, Lu G, et al. 2005, Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci USA 102:11402-11407.
75. Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, et al. 1999. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet 21:379-384.
76. Matsuura T, Yamagata T, Burgess DL, Rasmussen A, Grewal RP, et al, 2000 Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 26:191-194.
77. Holmes SE, O'Hearn EE, Mclnnis MG, Gorelick-Feldman DA, Kleiderlein JJ, et al. 1999. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat Genet 23:391-392.
78. Holmes SE, O'Hearn E, Rosenblatt A, Callahan C, Hwang HS, et al. 2001. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet 29:377-378.
79. Brown LY, Brown SA. 2004. Alanine tracts: the expanding story of human illness and trinucleotide repeats. Trends Genet 20:51-58.
80. Muragaki Y, Mundlos S, Upton J, Olsen BR. 1996. Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science 272:548-551.
81. Goodman FR. 2002. Limb malformations and the human HOX genes. Am J Med Genet 112:256-265.
82. Johnson KR, Sweet HO, Donahue LR, Ward-Bailey P, Bronson RT, et al. 1998. A new spontaneous mouse mutation of Hoxd13 with a polyalanine expansion and phenotype similar to human synpolydactyly. Hum Mol Genet 7:1033-1038.
83. Davis AP, Capecchi MR. 1996. A mutational analysis of the 5′ HoxD genes: dissection of genetic interactions during limb development in the mouse. Development 122:1175-1185.
84. Zakany J, Duboule D. 1996. Synpolydactyly in mice with a targeted deficiency in the HoxD complex. Nature 384:69-71.
85. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, et al. 1997. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89:773-779.
86. Brais B, Bouchard JP, Xie YG, Rochefort DL, Chretien N, et al. 1998. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18:164-167.
87. Calado A, Tome FM, Brais B, Rouleau GA, Kuhn U, et al. 2000. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum Mol Genet 9:2321-2328.
88. Fan X, Dion P, Laganiere J, Brais B, Rouleau GA. 2001. Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death. Hum Mol Genet 10:2341-2351.
89. Dorsman JC, Pepers B, Langenberg D, Kerkdijk H, Ijszenga M, et al. 2002. Strong aggregation and increased toxicity of polyleucine over polyglutamine stretches in mammalian cells. Hum Mol Genet 11:1487-1496.
90. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, et al. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
91. Bear MF, Huber KM, Warren ST. 2004. The mGluR theory of fragile X mental retardation. Trends Neurosci 27:370-377.
92. Garber K, Smith KT, Reines D, Warren ST. 2006. Transcription translation and fragile X syndrome. Curr Opin Genet Dev 16:270-275.
93. Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, et al. 1996. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271:1423-1427.
94. Voncken M, loannou P, Delatycki MB. 2004. Friedreich ataxia-update on pathogenesis and possible therapies. Neurogenetics 5:1-8.
95. Corben LA, Georgiou-Karistianis N, Fahey MC, Storey E, Churchyard A, et al. 2006. Towards an understanding of cognitive function in Friedreich ataxia. Brain Res Bull 70:197-202.
96. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, et al. 1999. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study-preliminary data. Am J Med Genet 83:322-325.
97. Marozzi A, Vegetti W, Manfredini E, Tibiletti MG, Testa G, et al. 2000. Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod 15:197-202.
98. Loesch DZ, Bui QM, Dissanayake C, Clifford S, Gould E, et al. 2007. Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neurosci Biobehav Rev 31:315-326.
99. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, et al. 2001 Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127-130.
100. Hagerman RJ, Ono MY, Hagerman PJ. 2005. Recent advances in fragile X: a model for autism and neurodegeneration. Curr Opin Psychiatry 18:490-496.
101. Brunberg JA, Jacquemont S, Hagerman RJ, Berry-Kravis EM, Grigsby J, et al. 2002. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol 23:1757-1766.
102. Loesch DZ, Litewka L, Brotchie P, Huggins RM, Tassone F, et al. 2005. Magnetic resonance imaging study in older fragile X premutation male carriers. Ann Neurol 58:326-330.
103. Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, et al. 2003. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72:869-878.
104. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, et al. 2000. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66:6-15.
105. Galvao R, Mendes-Soares L, Camara J, Jaco I, Carmo-Fonseca M. 2001, Triplet repeats, RNA secondary structure and toxic gain-of-function models for pathogenesis. Brain Res Bull 56:191-201.
106. Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, et al. 2005. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet 139:115-121.
107. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, et al. 1992. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 69:385.
108. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, et al. 1992. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256-1258.
109. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, et al. 1992. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253-1255.
110. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, et al. 2001. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864-867.
111. Mankodi A, Logigian E, Callahan L, McClain C, White R, et al. 2000. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289:1769-1773.
112. Cho DH, Tapscott SJ. 2007. Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 1772:195-204.
113. Lafreniere RG, Rochefort DL, Chretien N, Rommens JM, Cochius JI, etal. 1997. Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet 15:298-302.
114. Delgado-Escueta AV, Ganesh S, Yamakawa K. 2001. Advances in the genetics of progressive myoclonus epilepsy. Am J Med Genet 106:129-138.
115. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, et al. 1997. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17:79-83.